Researcher profile

Alexander Gusev

Alexander Gusev contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
1topics
3close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

SurvLatent ODE : A Neural ODE based time-to-event model with competing risks for longitudinal data improves cancer-associated Venous Thromboembolism (VTE) prediction

Effective learning from electronic health records (EHR) data for prediction of clinical outcomes is often challenging because of features recorded at irregular timesteps and loss to follow-up as well as competing events such as death or disease progression. To that end, we propose a generative time-to-event model, SurvLatent ODE, which adopts an Ordinary Differential Equation-based Recurrent Neural Networks (ODE-RNN) as an encoder to effectively parameterize dynamics of latent states under irregularly sampled input data. Our model then utilizes the resulting latent embedding to flexibly estimate survival times for multiple competing events without specifying shapes of event-specific hazard function. We demonstrate competitive performance of our model on MIMIC-III, a freely-available longitudinal dataset collected from critical care units, on predicting hospital mortality as well as the data from the Dana-Farber Cancer Institute (DFCI) on predicting onset of Venous Thromboembolism (VTE), a life-threatening complication for patients with cancer, with death as a competing event. SurvLatent ODE outperforms the current clinical standard Khorana Risk scores for stratifying VTE risk groups, while providing clinically meaningful and interpretable latent representations.

preprint2021arXiv

A General Framework for Survival Analysis and Multi-State Modelling

Survival models are a popular tool for the analysis of time to event data with applications in medicine, engineering, economics, and many more. Advances like the Cox proportional hazard model have enabled researchers to better describe hazard rates for the occurrence of single fatal events, but are unable to accurately model competing events and transitions. Common phenomena are often better described through multiple states, for example: the progress of a disease modeled as healthy, sick and dead instead of healthy and dead, where the competing nature of death and disease has to be taken into account. Moreover, Cox models are limited by modeling assumptions, like proportionality of hazard rates and linear effects. Individual characteristics can vary significantly between observational units, like patients, resulting in idiosyncratic hazard rates and different disease trajectories. These considerations require flexible modeling assumptions. To overcome these issues, we propose the use of neural ordinary differential equations as a flexible and general method for estimating multi-state survival models by directly solving the Kolmogorov forward equations. To quantify the uncertainty in the resulting individual cause-specific hazard rates, we further introduce a variational latent variable model and show that this enables meaningful clustering with respect to multi-state outcomes as well as interpretability regarding covariate values. We show that our model exhibits state-of-the-art performance on popular survival data sets and demonstrate its efficacy in a multi-state setting